Inve India ▾

Heranba Industries share price & results

Heranba Industries Limited· Chemicals· Commodities

Results to
Jun 2026
Latest analysed call
Q3 FY25
Ownership as of
Sept 2026

Gujarat-based integrated agrochemical manufacturer of synthetic pyrethroid insecticides, herbicides and fungicides, spanning intermediates, technicals and branded/export formulations plus public-health products.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue383 ₹ crore−15.3% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin12.8 %+5.9 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit7.0 ₹ crore+11.2% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.
Return on equity-9.40 %−9.8 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin-11.72 %−2.0 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)-2.56 %+0.9 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Guidance

What management said, and what became of it

8 targets tracked, none judged yet · 8 open · verdicts reflect calls analysed to Q3 FY25.

Heranba Industries Limited management guidance track record on Inve: 8 targets tracked across analysed earnings calls (0 achieved, 0 missed, 8 open).

TargetOriginal wordingSaidLatest callVerdict
Revenue Growth35% to 40% growth in FY25-26
Call transcript, Q3 FY25 · 27 Feb 2025		Q3 FY25Q3 FY25:Guided for 35-40% growth in FY26
Call transcript, Q3 FY25 · 27 Feb 2025		New

Source: Inve Guidance Tracker for Heranba Industries Limited · to Q3 FY25

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

8 of Heranba Industries Limited's 8 targets are still open. See which are on track and which have gone quiet. The 1 above are the free sample; 7 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹147.31 +0.75% · +₹1.1

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance −51.8% 1Y

₹150₹200₹250₹300Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26

1Y: ₹305.75 on 24 Oct 2025 → ₹147.31. High ₹305.75 (24 Oct 2025), low ₹146.21 (26 Oct 2026).

Previous close
₹146.21
Market cap
₹593 Cr
52-week range
₹146.21 – ₹302.9
One year
−51.37%
Return on equity (TTM to Jun 2026)
-9.40%

Overview

Symbol
NSE:HERANBA
Sector
Chemicals
Industry
Commodities
Exchange
NSE
Currency
INR

What Heranba Industries Limited does

Based on the company's own presentations, annual report and earnings calls.

Heranba Industries manufactures crop-protection chemicals across the full value chain: it makes intermediates (such as Cypermethric Acid Chloride) for captive use, converts them into technical-grade active ingredients (mainly synthetic pyrethroid insecticides, along with herbicides and fungicides), and formulates these into branded and export-ready pesticide products (EC, SC, WDG and similar formulations) as well as public-health pest-control products. Products are sold domestically through a large dealer network and exported to agrochemical companies and distributors across many countries. The company has also diversified into optical brightening agents, naphthol derivatives and textile auxiliaries through its acquired Daikaffil subsidiary, and is building a contract research and manufacturing (CRAMS/CRO) business serving agrochemical, pharmaceutical and specialty-chemical clients.

Segments

  • Intermediates
  • Technicals
  • Formulations
  • Daikaffil (specialty chemicals / CRAMS)
Manufacturing & packaging facilities
7 (Vapi, Sarigam, Saykha in Gujarat; Tarapur, Maharashtra)
Aggregate Technicals & Intermediates capacity
26,700 MTPA (FY25, up from 12,900 MTPA in FY24)
Aggregate Formulations capacity
30,000 MTPA (FY25, up from 25,000 MTPA in FY24)
Cumulative reactors installed across facilities
384 (FY25, up from 295 in FY24)
Total manufacturing area in use
1,24,970 sq. mt (plus 71,958 sq. mt available for expansion)
Cumulative product registrations
1,084 (spanning 54 countries; 183 more in pipeline)
Headquarters Mumbai, Maharashtra, IndiaEmployees 1,300 (FY25) Company website

Your own record

Start an Inve Case for Heranba Industries Limited

Free account: one company. Everything above stays public.

Write why you follow Heranba Industries Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Chemicals companies

All Chemicals companies → · Chemicals earnings growth →

Learn to analyse Heranba Industries Limited

Guides on how to read this kind of business and the numbers that matter.